Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole

Trial Profile

Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Palbociclib (Primary) ; Letrozole
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2017 Status changed from recruiting to active, no longer recruiting.
    • 18 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 23 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top